Authors / Dr. Michael Schell
Dr. Michael Schell
Team Leader Cell Technologies at Cenibra
Hi, I am Michael Schell and I am spreading the word of the great microscopy solutions offered by Yokogawa. My role encompasses several facets like selling the CQ1, establishing customer relationships, and offering customer support for image analysis workflows and on every level of the customer relationship. My strong curiosity and enthusiasm for biology, as well as my willingness to closely look at things (also by means of confocal microscopy), have been critical points when I chose to study biology and to obtain a Ph.D. in genetics before working with Yokogawa and Cenibra. Today, I believe that these skills guarantee successful working in this highly innovative environment of research and industry, where many new developments are happening right now and new trends like Deep-Learning and AI-driven confocal microscopy or single-cell manipulation getting more and more important. With this blog, we would like to emphasize topics of high relevance for our customers and for society.
All articles of Dr. Michael Schell
DRUG DISCOVERY / March 22, 2021
The research team of Prof. Prisca Liberali at the Friedrich Miescher Institute for Biomedical Research (FMI) in Basel explored the potential of organoids for drug screening in a unique image-based screening approach assaying an annotated library of compounds to elucidate tissue regenerative mechanisms in organoids.
Yokogawa decided to support the world’s fight against COVID-19, scientifically cooperating with research facilities actively involved in COVID-19 research. In those global collaborations, researchers will use the Yokogawa bench-top confocal quantitative image cytometer – the CellVoyager CQ1 microscope.